Last deal

$854.1K

Amount

Venture - Series Unknown

Stage

18.09.2014

Date

3

all rounds

$3.7M

Total amount

General

About Company
AvidBiotics is a biotherapeutics company that develops novel proteins to target bacteria, virus-infected cells, and cancers.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2004

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

Using a proprietary biotechnology-derived technology platform, AvidBiotics' proteins specifically flag virus-infected or cancerous cells for enhanced destruction by the Natural Killer and T-cells of the potent innate immunity systems. The company focuses on human therapeutic applications of its technologies, enabling physicians to activate the immune system to target and destroy cancer cells infected by viruses with laser precision.